Log in to search using one of your social media accounts:


FDA Approves First Pediatric Lopinavir/Ritonavir Oral Pellets for the Treatment of AIDS in Infants and Young Children

Mumbai, India - June 3, 2015 --Cipla Limited, a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients, today announced that it has received US FDA approval for an innovative...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news

Related Links:

More News: Children | HIV AIDS | Kaletra | Norvir | Pediatrics | Pharmaceuticals